Advancing CIDP Care: Jamie Morrell Publishes New Research in Muscle & Nerve
We’re proud to share that Jamie Morrell, Vice President of PromptCare’s Neurology Program, contributes to a new peer-reviewed article in Muscle & Nerve, a leading clinical research journal devoted to publishing studies on the most important findings on neuromuscular disorders and treatment options. The publication, “Practical Approach to Managing SCIg Treatment in Patients with Chronic Inflammatory Demyelinating Polyneuropathy,” offers real-world guidance to help clinicians manage subcutaneous immunoglobulin (SCIg) therapy dosing and support long-term stability for patients with CIDP.
Chronic inflammatory demyelinating polyneuropathy (CIDP) requires ongoing, individualized care. Immunoglobulin therapy remains a cornerstone of treatment, and for many patients, subcutaneous immunoglobulin (SCIg) provides an effective option that supports treatment at home.
Jamie Morrell joins an esteemed team of clinicians and experts in developing practical guidance for SCIg management, now published in the peer-reviewed journal Muscle & Nerve. The article translates clinical experience into clear strategies that help providers manage therapy with confidence in everyday practice.
Practical Guidance for Everyday Care
Successful SCIg therapy depends on more than clinical efficacy. Providers make ongoing decisions that shape long-term outcomes. The research addresses key considerations, including:
- Identifying appropriate candidates for SCIg
- Transitioning patients from IVIg to SCIg
- Individualizing dosing and administration schedules
- Monitoring response and recognizing early signs of relapse
- Supporting patient education and long-term adherence
This collaborative work reflects a growing focus on treatment approaches that support both clinical stability and patient independence.
Why SCIg Matters
For many patients managing a CIDP diagnosis, SCIg offers meaningful advantages:
- More consistent immunoglobulin levels
- Flexibility to self-administer at home
- Reduced treatment burden
- Greater independence and quality of life
These benefits depend on strong training, ongoing clinical oversight, and close coordination with the prescribing neurologist.
Supporting Neurology Patients Every Day
Our neurology program at PromptCare applies these same principles to care for patients with CIDP and other complex neurological conditions. We work alongside referring providers to ensure patients start and stay successful on therapy through:
- Comprehensive patient education and self-infusion training
- Experienced infusion nurses, pharmacists, and clinical specialists
- Specialty pharmacy dispensing in all 50 states
- Ongoing monitoring and adherence support
- Around-the-clock clinical availability and oversight
PromptCare serves as an extension of the provider’s care team, helping patients manage therapy safely at home while keeping physicians informed and supported.
About Jamie Morrell, Vice President of Neurology Program
Jamie Morrell oversees PromptCare’s Neurology Program. Her work centers on optimizing therapy, expanding access to in-home treatment, and improving long-term patient outcomes. She contributes to clinical education and collaborative research, including Muscle & Nerve.
Whatever It Takes.
Refer a patient or learn more about our comprehensive neurology services:
p 866-776-6782
f 800-815-6808
